Importance of quality of life in early phase clinical trials: A case study of selinexor in multiple myeloma

Br J Haematol. 2020 May;189(3):e112-e113. doi: 10.1111/bjh.16532. Epub 2020 Feb 20.
No abstract available

Keywords: multiple myeloma; quality of life; selinexor.

Publication types

  • Letter

MeSH terms

  • Humans
  • Hydrazines / pharmacology
  • Hydrazines / therapeutic use*
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Quality of Life / psychology*
  • Survival Analysis
  • Triazoles / pharmacology
  • Triazoles / therapeutic use*

Substances

  • Hydrazines
  • Triazoles
  • selinexor